FAM86B1
Putative protein N-methyltransferase FAM86B1
Also known as: F86B1_HUMAN, MGC16279
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N7N1
- Gene
- FAM86B1
- Ensembl
- ENSG00000186523
- Chromosome
- 8
- Canonical length
- 330 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable protein-lysine N-methyltransferase activity. Predicted to be involved in methylation. Predicted to be part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
330 residues, UniProt reviewed canonical sequence.
>Q8N7N1|FAM86B1
1 MAPEENAGTE LLLQGFERRF LAVRTLRSFP WQSLEAKLRD SSDSELLRDI LQKTVRHPVC
61 VKHPPSVKYA WCFLSELIKK HEAVHTEPLD KLYEVLTETL MAKESTQGHR SYLLSSGGSV
121 TLSKSTAIIS HGTTGLVTWD AALYLAEWAI ENPAAFINRT VLELGSGAGL TGLAICKMCR
181 PRAYIFSDPH SRVLEQLRGN VLLNGLSLEA DITGNLDSPR VTVAQLDWDV AMVHQLSAFQ
241 PDVVIAADVL YCPEAIVSLV GVLQRLAACR EHKRAPEVYV AFTVRNPETC QLFTTELGRD
301 GIRWEAEAHH DQKLFPYGEH LEMAMLNLTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM86B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 7.3 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 7.3 nTPM
- pituitary gland: 6.9 nTPM
- cerebellum: 6.2 nTPM
- cerebral cortex: 5.5 nTPM
- hypothalamus: 4.5 nTPM
- ovary: 4.4 nTPM
Single-cell type
- ependymal cells: 5.2 nCPM
- proximal tubule cells: 3.8 nCPM
- epididymal efferent duct ciliated cells: 2.9 nCPM
- choroid plexus epithelial cells: 2.6 nCPM
- renal collecting duct principal cells: 2.5 nCPM
- medullary thymic epithelial cells: 2.4 nCPM
Immune cell
- neutrophil: 1.3 nTPM
- basophil: 1.1 nTPM
- eosinophil: 1.1 nTPM
- memory B-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- cerebral cortex: 50 nTPM
- basal ganglia: 44 nTPM
- hippocampal formation: 42 nTPM
- amygdala: 39 nTPM
- white matter: 37 nTPM
- hypothalamus: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.84
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.17
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM86B1 as an antibody target. Whether an autoantibody or antibody against FAM86B1 could matter depends on whether native FAM86B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM86B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM86B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...